Arcturus Therapeutics Holdings Inc. ARCT announced that the FDA has granted a Fast Track designation to its self-amplifying ...

Novavax shifts to a partnership-focused strategy with a $500M Sanofi deal. Despite regulatory and competitive risks. See why ...

Knowable Magazine answers questions about how dangerous bird flu is, where it came from, and what key events paved the way ...

The new nasal vaccine only needs one dose and produces reliable immunity right at the site where the virus enters the body.

The University of Maryland and USDA Agricultural Research Service researchers have secured $648,881 to develop a nasal vaccine that can prevent H5N1 bird flu in dairy cows. The funding comes from the ...

Arcturus Therapeutics Holdings has won U.S. Food and Drug Administration fast-track designation for its ARCT-2304 pandemic flu vaccine candidate.

Arcturus Therapeutics (ARCT) announced that the FDA has granted fast track designation for the self-amplifying mRNA vaccine candidate, ...

This isn’t just an animal health crisis — it’s a risk to public health. When animals consume foods containing live virus, ...

A chewing gum made from lablab beans may be the next big tool in fighting viral transmission. Scientists found that this gum can neutralize influenza and herpes viruses by over 95% by targeting the ...

To reduce mortality and morbidity from influenza in humans, vaccines remain the most important intervention. As part of ongoing work related to pandemic prevention and preparedness, WHO held a ...

Scientists have pioneered an influenza virus vector-based nasal spray vaccine platform and developed a nasal spray H5N1 avian influenza vaccine. During the early COVID-19 pandemic, this platform ...

A 3-year-old girl in western Mexico has died after contracting bird flu in the country's first confirmed human case of the virus, Mexican health authorities said Tuesday. Mexico's Health Ministry said ...